Literature DB >> 24003924

Infectious triggers in type 1 diabetes: is there a case for epitope mimicry?

G Afonso1, R Mallone.   

Abstract

Environmental factors are the main contributors to type 1 diabetes (T1D) pathogenesis, yet they remain unidentified. Enteroviruses are proposed candidate triggers due to temporal correlations between infection and T1D autoimmunity and to detection of viral proteins in diseased islets. However, such correlations are not universal and may be relatively uncommon. Furthermore, evidence of a cause-effect relationship is lacking, as infection of non-obese diabetic mice with Coxsackie enteroviruses can either trigger or blunt disease. The proposed mechanisms are either non-antigen-specific (i.e. β-cell destruction and release of sequestered antigens, islet inflammation) or antigen-specific (i.e. epitope mimicry, by which immune responses to enteroviruses may be diverted against homologous β-cell antigens). The case for the latter mechanisms is even less stringent, as there is little evidence of promiscuous antigen recognition at the single T-cell level. Other infectious agents may thus be implicated. Demonstration of their role will require fulfilling the Koch's postulates, namely isolation of the agent preferentially in T1D patients, including before disease onset; and T1D induction when the agent is inoculated into mice. The same is needed for cross-reactive T cells to support epitope mimicry mechanisms. Generation of alternative (humanized) mouse models that could be challenged with candidate microbes is needed.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  NOD mouse; T cells; antigen; autoimmunity; enterovirus; epitope

Mesh:

Substances:

Year:  2013        PMID: 24003924     DOI: 10.1111/dom.12166

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  9 in total

Review 1.  Combination immunotherapies for type 1 diabetes mellitus.

Authors:  Paolo Pozzilli; Ernesto Maddaloni; Raffaella Buzzetti
Journal:  Nat Rev Endocrinol       Date:  2015-02-17       Impact factor: 43.330

2.  The challenges of solid tumor for designer CAR-T therapies: a 25-year perspective.

Authors:  Richard P Junghans
Journal:  Cancer Gene Ther       Date:  2017-03       Impact factor: 5.987

Review 3.  Type 1 diabetes and polyglandular autoimmune syndrome: A review.

Authors:  Martin P Hansen; Nina Matheis; George J Kahaly
Journal:  World J Diabetes       Date:  2015-02-15

4.  Isolation of human monoclonal autoantibodies derived from pancreatic lymph node and peripheral blood B cells of islet autoantibody-positive patients.

Authors:  Mara Catani; Denise Walther; Michael R Christie; Kerry A McLaughlin; Ezio Bonifacio; Anne Eugster
Journal:  Diabetologia       Date:  2016-02       Impact factor: 10.122

Review 5.  Beta-cell Specific Autoantibodies: Are they Just an Indicator of Type 1 Diabetes?

Authors:  Georgia Fousteri; Elio Ippolito; Rizwan Ahmed; Abdel Rahim A Hamad
Journal:  Curr Diabetes Rev       Date:  2017

Review 6.  Autoreactive T cells in type 1 diabetes.

Authors:  Alberto Pugliese
Journal:  J Clin Invest       Date:  2017-08-01       Impact factor: 14.808

Review 7.  Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes.

Authors:  Jessica L Dunne; Sarah J Richardson; Mark A Atkinson; Maria E Craig; Knut Dahl-Jørgensen; Malin Flodström-Tullberg; Heikki Hyöty; Richard A Insel; Åke Lernmark; Richard E Lloyd; Noel G Morgan; Alberto Pugliese
Journal:  Diabetologia       Date:  2019-01-23       Impact factor: 10.122

Review 8.  Neglected Facts on Mycobacterium Avium Subspecies Paratuberculosis and Type 1 Diabetes.

Authors:  Veronika Ozana; Karel Hruska; Leonardo A Sechi
Journal:  Int J Mol Sci       Date:  2022-03-26       Impact factor: 5.923

9.  Altered Macrophage and Dendritic Cell Response in Mif-/- Mice Reveals a Role of Mif for Inflammatory-Th1 Response in Type 1 Diabetes.

Authors:  Yuriko Itzel Sánchez-Zamora; Imelda Juarez-Avelar; Alicia Vazquez-Mendoza; Marcia Hiriart; Miriam Rodriguez-Sosa
Journal:  J Diabetes Res       Date:  2016-09-06       Impact factor: 4.011

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.